AI assistant
Sending…
Edwards Lifesciences Corp — Director's Dealing 2012
Aug 8, 2012
30042_dirs_2012-08-08_11e019b2-396e-4fd6-a11a-c18a46ca8b79.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2012-08-06
Reporting Person: WANG HUIMIN (CVP, Japan & Intercontinental)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-08-06 | Common Stock | M | 6250.0000 | $21.9550 | Acquired | 53417.1278 | Direct |
| 2012-08-06 | Common Stock | S | 6250.0000 | $100.0900 | Disposed | 47167.1278 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-08-06 | Employee Stock Option (Right to Acquire) | $21.9550 | M | 6250.0000 | Disposed | 2013-05-10 | Common Stock (6250.0000) | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 2, 2011.
F2: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
More from Edwards Lifesciences Corp
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 8
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 27
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 17